|    Books   |    Videos   |    Join us   |    Login   |    More

Blog, comment, reply, share links, ideas, videos, pictures and podcasts

Researchers in Cuba developed CIMAvax, a recombinant anti-human epidermal growth factor immunotherapy. Studies conducted there showed a survival benefit for patients with advanced NSCLC who received CIMAvax as maintenance therapy following combination chemotherapy. The Cuban-developed immunotherapy CIMAvax-EGF in combination with nivolumab appeared safe for patients with advanced non-small cell lung cancer, according to results from trials.

Cuba has a lung cancer vaccine. Many U.S. patients can’t get it without breaking the law

President Trump’s tightened travel to Cuba makes it harder to go there. Some U.S. cancer patients say they have no other options.
12345678910  Next